# Specification Quality Checklist: Patient-Grouped Safety Dataset Builder for Safira

**Purpose**: Validate specification completeness and requirements quality before technical planning.
**Created**: 2026-10-17
**Feature**: [Feature 003 specification](../spec.md)

## Content Quality

- [x] No implementation details (languages, frameworks, APIs).
- [x] Focused on user value and business needs.
- [x] Written for non-technical stakeholders.
- [x] All mandatory sections completed.

## Requirement Completeness

- [ ] No [NEEDS CLARIFICATION] markers remain.
- [ ] Requirements are testable and unambiguous.
- [x] Success criteria are measurable.
- [x] Success criteria are technology-agnostic (no implementation details).
- [x] All acceptance scenarios are defined.
- [x] Edge cases are identified.
- [x] Scope is clearly bounded.
- [x] Dependencies and assumptions identified.

## Feature Readiness

- [ ] All functional requirements have clear acceptance criteria.
- [x] User scenarios cover primary flows.
- [x] Feature meets measurable outcomes defined in Success Criteria.
- [x] No implementation details leak into specification.

## Notes

- Review result: **13/16 items satisfied; clarification required before planning**. Checked items describe specification quality, not completed implementation or evidence of clinical validity.
- Three intentional clarification markers remain: FR-004/C1, FR-011/C2 and FR-012/C3. They concern the admissible verification/independence evidence, patient linkage authority and research allocation/adequacy/protected-test protocol. These choices are not silently defaulted.
- The three incomplete criteria reflect those unresolved decisions. For example, FR-004 requires "independently verified against authoritative source evidence" but the admissible authorities/evidence remain C1; FR-011 requires a "stable opaque patient grouping identity" with C2 defining the verified equivalence source; FR-012 requires an "explicit reproducible configuration" with C3 defining the research protocol. Behavioral acceptance scenarios and outcome measures are specified, but protocol-dependent acceptance cannot be finalized until these answers are approved.
- Existing contract references identify dependencies and preservation requirements; the specification introduces no new operation signatures, storage choices, algorithms, services or code layout.
- Review coverage: source-qualified supervised joins and binary correctness (US1; FR-001–010; SC-001/005), patient isolation/overlap/duplicates (US2; FR-011–014; SC-002), independence and protected testing (US3; FR-005/015–017; SC-003/007), reproducibility/privacy (US4; FR-021–024; SC-004/007), limited data and imbalance (US5; FR-018–020; SC-006), scope and synthetic regression verification (FR-025–026; SC-008).
- Constitution v3.0.0 is preserved. All three classifier configurations, independent patient grouping, held-out calibration, protected final evaluation, explicit evidence absence and the research prototype boundary are represented.
- Next phase: `$speckit-clarify`. Do not treat this draft as approved for technical planning while C1–C3 remain unresolved.
